STACY MCENANEY: Open Payments
NPI 1467958819 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,019 in 118 payments from 17 companies in 2025. Trend: 2023 $2,443 · 2024 $1,135 · 2025 $2,019
Food & beverage: $1,909Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $377 |
| Janssen Biotech, Inc. | 28 | $335 |
| UCB, Inc. | 6 | $175 |
| Organon LLC | 11 | $162 |
| Galderma Laboratories, L.P. | 12 | $152 |
| Lilly USA, LLC | 9 | $141 |
| E.R. Squibb & Sons, L.L.C. | 9 | $135 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $69 |
Products named: TREMFYA, RINVOQ, Bimzelx, Sotyktu, SKYRIZI, DUPIXENT, NEMLUVIO, TALTZ.
Industry payments across TX — which companies pay providers there.
